Impact of Timing following Acute Myocardial Infarction on Efficacy and Safety of Bone Marrow Stem Cells Therapy: A Network Meta-Analysis

@inproceedings{Liu2016ImpactOT,
  title={Impact of Timing following Acute Myocardial Infarction on Efficacy and Safety of Bone Marrow Stem Cells Therapy: A Network Meta-Analysis},
  author={Bei Liu and Chong-yang Duan and Cheng-feng Luo and Cai-Wen Ou and Zhi-Ye Wu and Jian-wu Zhang and Xiao-Bin Ni and Pingyan Chen and Min-sheng Chen},
  booktitle={Stem cells international},
  year={2016}
}
Background. The optimal timing for Bone Marrow Stem Cells (BMCs) therapy following acute myocardial infarction (AMI) remains unclear. Aims. To synthesize the evidence from trials using a multiple-treatment comparison method, thereby permitting a broader comparison across multiple timing of BMCs therapy. Methods and Results. Randomized controlled trials in patients with AMI receiving BMCs therapy were identified from PubMed, Ovid LWW, BIOSIS Previews, and the Cochrane Library through January… CONTINUE READING